Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: A randomized, controlled comparative study

British Journal of Dermatology

Volumn 164, Issue 6, 2011, Pages 1369-1375

  Lee, J W ^a   Yoo, K H ^a   Park, K Y ^a   Han, T Y ^a   Li, K ^a   Seo, S J ^a   Hong, C K ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHAPPED LIPS; CONTROLLED STUDY; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG TOLERABILITY; DRY SKIN; EPISTAXIS; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ISOTRETINOIN; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79957622731     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10152.x     Document Type: Article

References (16)

1. Amichai B, Grunwald MH,. Isotretinoin in dermatology. J Dermatolog Treat 2000; 11: 219-40. (Pubitemid 32098638)
2. Cunliffe WJ, van de Kerkhof PCM, Caputo R, et al. Roaccutane treatment guidelines: results of an international survey. Dermatology 1997; 194: 351-7. (Pubitemid 27290560)
3. Kaymak Y, Ilter N,. The effectiveness of intermittent isotretinoin treatment in mild or moderate acne. J Eur Acad Dermatol Venereol 2006; 20: 1256-60. (Pubitemid 44614625)
4. Amichai B, Shemer A, Grunwald MH,. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006; 54: 644-6.
5. Goulden V, Clark SM, McGeown C, Cunliffe WJ,. Treatment of acne with intermittent isotretinoin. Br J Dermatol 1997; 137: 106-8. (Pubitemid 27305920)
6. Mandekou-Lefaki I, Delli F, Teknetzis A, et al. Low-dose schema of isotretinoin in acne vulgaris. Int J Clin Pharmacol Res 2003; 23: 41-6. (Pubitemid 38282333)
7. Akman A, Durusoy C, Senturk M, et al. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Arch Dermatol Res 2007; 299: 467-73. (Pubitemid 350160055)
8. Sardana K, Garg VK, Sehgal VN, et al. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris. J Eur Acad Dermatol Venereol 2009; 23: 556-60.
9. Doshi A, Zaheer A, Stiller MJ,. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol 1997; 36: 416-18.
10. Demircay Z, Kus S, Sur H,. Predictive factors for acne flare during isotretinoin treatment. Eur J Dermatol 2008; 18: 452-6. (Pubitemid 352031857)
11. Rivera AE,. Acne scarring: a review and current treatment modalities. J Am Acad Dermatol 2008; 59: 659-76.
12. Melnik BC,. FoxO1-the key for the pathogenesis and therapy of acne? J Dtsch Dermatol Ges 2010; 8: 105-14.
13. Ellis CN, Krach KJ,. Uses and complications of isotretinoin therapy. J Am Acad Dermatol 2001; 45: 150-7.
14. Azoulay L, Oraichi D, Bérard A,. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study. Br J Dermatol 2007; 157: 1240-8. (Pubitemid 350115707)
15. Layton AM, Knaggs HT, Cunliffe WJ,. Isotretinoin for acne vulgaris-10 years: a safe and successful treatment. Br J Dermatol 1993; 129: 292-6. (Pubitemid 23284001)
16. White GM, Chen W, Yao J, Wolde-Tsadik G,. Recurrence rates after the first course of isotretinoin. Arch Dermatol 1998; 134: 376-8. (Pubitemid 28141632)